A study by Tarallo et al reported that NLRP3 is expressed in RPE cells in human non-exudative AMD and that targeting the NLRP3 inflammasome or IL-18 could inhibit RPE-degeneration (Tarallo et al., 2012). This evidence concerns the gene NLRP3 and age-related macular degeneration.